Treating Patients with Non-Driver Mutations mNSCLC
Experts share insights on the use chemotherapy and immunotherapy in driver-negative patients, along with the use of PD-L1 inhibitors.
Precision Medicine Bridging Gaps Patients Without Driver Mutations Non Driver Mutations Squamous Cancer Driver Alterations
Source: ajmc.com